Notably, VSL#3 treatment upregulated the expression of microRNA-146a and blocked the BTG2/Bax axis in PND mice, thereby reducing oxidative stress and neuroinflammation (Mao et al., 2021)
Regulatory & Availability Status Not approved by FDA or any regulator
J Am Coll Cardiol 48(8):16881697 Xu J, Wang G, Wang Y, Liu Q, Xu W, Tan Y et al (2009) Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection
We do not publish dosing figures because they are not a safe substitute for a providers assessment
However, Eli Lilly released promising trial results in March, claiming patients lost an average 28 percent of their weight over 80 weeks while on the drug, approaching the effectiveness of far more invasive bariatric surgery
-1 -1